AG3
AG3 is an inorganic-binding polypeptide that specifically recognizes Ag/Au surfaces. In silver systems, AG3 induces the reduction of Ag+ and regulates microcrystal morphology. In gold systems, AG3 acts as a non-reducing, high-affinity inhibitor that modulates nucleation-growth kinetics through interactions with metal clusters/surfaces to achieve size/morphology control. AG3 can be immobilized on polymer films, phages or nanosubstrates for applications in biomimetic mineralization, biosensors, precious metal recovery and patterned graphite templates.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 557064-55-8
- Formule: C57H80N12O16S
- Masse moléculaire:1221.38
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
AG3 promotes the reduction of Ag+ to Ag0[1] during in vitro biomimetic synthesis.
AG3 can induce the formation of hexagonal, triangular and cubic silver microcrystal morphologies in vitro; its secondary structure in solution undergoes only minor changes after binding to silver[1].
AG3 inhibits the nucleation and surface reaction-limited growth processes of Au nanocrystals formed from Au (III) ions[2].
AG3 cannot reduce gold ions independently; it modulates the HEPES-mediated AuIII reduction mechanism, thereby preventing the formation of irregular precipitates[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 557064-55-8
-
Masse moléculaire 1221.38
-
Formule C57H80N12O16S
-
Sequence
Ala-Tyr-Ser-Ser-Gly-Ala-Pro-Pro-Met-Pro-Pro-Phe
-
Sequence Shortening
AYSSGAPPMPPF
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Mesenchymal stromal/stem cell osteogenic differentiation
Mesenchymal stromal/stem cells can be induced toward an osteoblast-like lineage in vitro by culture in osteogenic medium containing dexamethasone, ascorbic acid or ascorbate-2-phosphate, and β-glycerophosphate; the differentiation process is commonly evaluated by alkaline phosphatase activity, osteogenic marker expression, collagenous matrix formation, and calcium-rich matrix mineralization. The main readouts are alkaline phosphatase activity as an early osteogenic marker and Alizarin Red S staining as a calcium-deposit readout for mineralized extracellular matrix; Alizarin Red S can be inspected microscopically or extracted and measured colorimetrically at 405 nm.
-
Cell Counting-Based Growth Curve Assay
Cell counting-based growth curve assays quantify cell proliferation by directly measuring changes in viable cell number over time using manual or automated counting methods such as hemocytometer-based counting or instrument-assisted cell enumeration, enabling construction of growth curves that reflect population expansion dynamics in response to culture conditions. A widely used approach is trypan blue exclusion with hemocytometer counting, where membrane-compromised (non-viable) cells take up the dye, allowing discrimination between viable and non-viable cells while simultaneously enabling total cell number quantification. Repeated sampling across time points allows estimation of proliferation rate, growth phases, and comparative growth kinetics between experimental conditions.
Pureté et documentation
Références
[1]. Zhang X, et al. Biomimetic synthesis silver crystallite by peptide AYSSGAPPMPPF immobilized on PET film in vitro. Journal of inorganic biochemistry. 2005 Aug;99(8):1692-7. [Content Brief]
[2]. Stanley SK, et al. Inhibitory effects of a phage-derived peptide on Au nanocrystal nucleation and growth. Langmuir : the ACS journal of surfaces and colloids. 2009 Sep 15;25(18):10886-92. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)